BSL-BIOSERVICE Scientific Laboratories GmbH
BSL BIOSERVICE is an internationally active Contract Research Organization (CRO) established in 1995, specializing in biological safety and activity testing services for BioPharmaceuticals, Chemicals, Medical Devices, Agrochemicals, and Food. The company is committed to high quality, flexibility, and customer orientation, supporting clients from early research to finalization of pre-clinical studies. It is accredited with DIN EN ISO 17025, certified in accordance with GLP, and fully accredited by AAALAC International. BSL BIOSERVICE collaborates with a global network of laboratories and partners to deliver comprehensive testing and regulatory support, contributing to global health, safety, and environment.
Industries
Nr. of Employees
small (1-50)
BSL-BIOSERVICE Scientific Laboratories GmbH
Behringstraße 6/8, 82152 Planegg/Munich, Germany
Services
Preclinical assessment, ADME, IND-enabling toxicology/PK studies, immunotoxicology and bioassays for later-stage development and batch release.
Comprehensive safety testing portfolio covering genetic toxicology, acute and repeated dose toxicity, DART, carcinogenicity and endocrine disruption across product types.
Batch release bioassays and pharmacopoeial testing for excipients, raw materials and finished products to demonstrate compliance and product quality.
Biocompatibility testing per ISO 10993 series and microbiological testing including sterility, endotoxin, bioburden and validation of microbiological methods.
Toxicology, dermal absorption, mode-of-action and partnered ecotoxicology and field studies to support agrochemical and biocide registration.
Toxicokinetics, subchronic and chronic toxicity, genotoxicity, immunotoxicity and allergenicity testing designed to meet EFSA and EC requirements for food additive evaluation.
Preclinical assessment, ADME, IND-enabling toxicology/PK studies, immunotoxicology and bioassays for later-stage development and batch release.
Comprehensive safety testing portfolio covering genetic toxicology, acute and repeated dose toxicity, DART, carcinogenicity and endocrine disruption across product types.
Batch release bioassays and pharmacopoeial testing for excipients, raw materials and finished products to demonstrate compliance and product quality.
Biocompatibility testing per ISO 10993 series and microbiological testing including sterility, endotoxin, bioburden and validation of microbiological methods.
Toxicology, dermal absorption, mode-of-action and partnered ecotoxicology and field studies to support agrochemical and biocide registration.
Toxicokinetics, subchronic and chronic toxicity, genotoxicity, immunotoxicity and allergenicity testing designed to meet EFSA and EC requirements for food additive evaluation.
Expertise Areas
- Preclinical safety assessment
- Toxicology testing (chemical, agrochemical, pharmaceutical)
- Biocompatibility and medical device testing
- Pharmacology and in vivo efficacy testing
Key Technologies
- In vivo animal models
- ADME studies (including radiolabelled in vivo ADME)
- Pharmacokinetic / toxicokinetic analysis
- Bioanalytical assays
News & Updates
BSL BIOSERVICE supports drug development from early research to commercialization, including proof of concept, ADME, toxicology, immunotoxicology, and bioassays for batch release.
BSL BIOSERVICE earned full accreditation from AAALAC International for its animal facility in February 2014.
BSL BIOSERVICE supports drug development from early research to commercialization, including proof of concept, ADME, toxicology, immunotoxicology, and bioassays for batch release.
BSL BIOSERVICE earned full accreditation from AAALAC International for its animal facility in February 2014.